Skip to content

Released Aug 7, 2019, before the open

10-Q filed Aug 7, 2019, 38 days after period end · 0001144204-19-038038

Q2 2019 · 10-Q
Revenue$0.00— vs Q2 2018no prior Q1 2019 on file
Net Income-$3.43MN/M vs Q2 2018N/M vs Q1 2019
EPS Diluted-$0.14N/M vs Q2 2018N/M vs Q1 2019
Operating Income-$3,350,603N/M
Operating Cash Flowderived-$2,557,928N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2019Q2 2018Q2 2017Q2 2016
Revenue$0.00$0.00$0.00—
Net Income-$3.43M-$3.26M-$6.09M-$5.76M
EPS Diluted-$0.14-$0.15-$0.31-$0.32

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR